Zevin Asset Management LLC Has $9.83 Million Holdings in Colgate-Palmolive Company $CL

Zevin Asset Management LLC decreased its position in shares of Colgate-Palmolive Company (NYSE:CL) by 6.4% in the 3rd quarter, HoldingsChannel reports. The firm owned 122,990 shares of the company’s stock after selling 8,356 shares during the quarter. Colgate-Palmolive accounts for 1.4% of Zevin Asset Management LLC’s portfolio, making the stock its 29th largest holding. Zevin Asset Management LLC’s holdings in Colgate-Palmolive were worth $9,832,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Westerkirk Capital Inc. acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter worth approximately $1,012,000. Premier Fund Managers Ltd boosted its holdings in shares of Colgate-Palmolive by 2.7% in the 3rd quarter. Premier Fund Managers Ltd now owns 112,538 shares of the company’s stock valued at $9,050,000 after purchasing an additional 3,000 shares in the last quarter. Advisors Preferred LLC bought a new position in shares of Colgate-Palmolive in the 3rd quarter valued at $232,000. Lansforsakringar Fondforvaltning AB publ lifted its position in shares of Colgate-Palmolive by 3.3% during the 3rd quarter. Lansforsakringar Fondforvaltning AB publ now owns 246,586 shares of the company’s stock worth $19,712,000 after buying an additional 7,986 shares during the last quarter. Finally, Advyzon Investment Management LLC boosted its stake in Colgate-Palmolive by 11.6% in the third quarter. Advyzon Investment Management LLC now owns 3,767 shares of the company’s stock valued at $301,000 after buying an additional 392 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. Argus reissued a “hold” rating on shares of Colgate-Palmolive in a report on Thursday, December 11th. Jefferies Financial Group upped their price objective on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the stock a “hold” rating in a research report on Monday, February 2nd. Rothschild & Co Redburn set a $93.00 target price on shares of Colgate-Palmolive in a research report on Friday, February 13th. Royal Bank Of Canada upgraded shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price target for the company in a report on Tuesday, December 9th. Finally, Morgan Stanley raised their price objective on Colgate-Palmolive from $87.00 to $100.00 and gave the company an “overweight” rating in a report on Monday, February 2nd. Eleven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average price target of $94.75.

Colgate-Palmolive Stock Up 1.2%

Shares of NYSE:CL opened at $95.07 on Monday. The firm has a market cap of $76.63 billion, a P/E ratio of 36.29, a P/E/G ratio of 4.29 and a beta of 0.29. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $100.18. The business has a fifty day simple moving average of $85.61 and a 200 day simple moving average of $82.25. The company has a quick ratio of 0.27, a current ratio of 0.42 and a debt-to-equity ratio of 5.90.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. The company had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The firm’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the firm earned $0.91 earnings per share. Analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st were given a dividend of $0.52 per share. The ex-dividend date was Wednesday, January 21st. This represents a $2.08 annualized dividend and a dividend yield of 2.2%. Colgate-Palmolive’s dividend payout ratio is 79.39%.

Insider Activity

In other news, insider Sally Massey sold 15,851 shares of Colgate-Palmolive stock in a transaction dated Thursday, February 5th. The stock was sold at an average price of $95.03, for a total value of $1,506,320.53. Following the completion of the transaction, the insider directly owned 13,751 shares of the company’s stock, valued at approximately $1,306,757.53. This trade represents a 53.55% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Stanley J. Sutula III sold 97,843 shares of the business’s stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total value of $9,223,659.61. Following the completion of the transaction, the chief financial officer directly owned 55,310 shares in the company, valued at $5,214,073.70. This represents a 63.89% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 184,683 shares of company stock worth $17,486,693 over the last ninety days. Corporate insiders own 0.41% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.